Literature DB >> 18553055

The emerging CK2 interactome: insights into the regulation and functions of CK2.

Laszlo Gyenis1, David W Litchfield.   

Abstract

Protein kinase CK2 represents a small family of protein serine/threonine kinases implicated in a variety of biological processes including events relating to cell proliferation and survival. Notably, CK2 displays oncogenic activity in mice and exhibits altered expression in several types of cancer. Accordingly, a detailed understanding of the cellular functions of CK2 and elucidation of the mechanisms by which CK2 is regulated in cells is expected to contribute to understanding its role in tumorigenesis with the prospect of novel approaches to therapy. While CK2 has traditionally been viewed as a tetrameric complex composed of two catalytic and two regulatory subunits, mounting evidence suggests that its subunits may have functions independent of tetrameric CK2 complexes. In mammals, as is the case in the budding yeast Saccharomyces cerevisiae, there are two isozymic forms of CK2, adding additional heterogeneity to the CK2 family. Studies in yeast and in human cells demonstrate that the different forms of CK2 interact with a large number of cellular proteins. To reveal new insights regarding the regulation and functions of different forms of CK2, we have examined the emerging interactomes for each of the CK2 subunits. Analysis of these interactomes for both yeast and human CK2 reinforces the view that this family of enzymes participates in a broad spectrum of cellular events. Furthermore, while there is considerable overlap between the interactomes of the individual CK2 subunits, notable differences in each of the individual interactomes provides additional evidence for functional specialization for the individual forms of CK2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553055     DOI: 10.1007/s11010-008-9830-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  77 in total

Review 1.  The regulation of protein function by multisite phosphorylation--a 25 year update.

Authors:  P Cohen
Journal:  Trends Biochem Sci       Date:  2000-12       Impact factor: 13.807

2.  Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.

Authors:  Moira M Messenger; Ronald B Saulnier; Andrew D Gilchrist; Phaedra Diamond; Gary J Gorbsky; David W Litchfield
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

Review 3.  Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

Authors:  James S Duncan; David W Litchfield
Journal:  Biochim Biophys Acta       Date:  2007-08-30

4.  Functional organization of the yeast proteome by systematic analysis of protein complexes.

Authors:  Anne-Claude Gavin; Markus Bösche; Roland Krause; Paola Grandi; Martina Marzioch; Andreas Bauer; Jörg Schultz; Jens M Rick; Anne-Marie Michon; Cristina-Maria Cruciat; Marita Remor; Christian Höfert; Malgorzata Schelder; Miro Brajenovic; Heinz Ruffner; Alejandro Merino; Karin Klein; Manuela Hudak; David Dickson; Tatjana Rudi; Volker Gnau; Angela Bauch; Sonja Bastuck; Bettina Huhse; Christina Leutwein; Marie-Anne Heurtier; Richard R Copley; Angela Edelmann; Erich Querfurth; Vladimir Rybin; Gerard Drewes; Manfred Raida; Tewis Bouwmeester; Peer Bork; Bertrand Seraphin; Bernhard Kuster; Gitte Neubauer; Giulio Superti-Furga
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

5.  Yeast holoenzyme of protein kinase CK2 requires both beta and beta' regulatory subunits for its activity.

Authors:  Konrad Kubiński; Katarzyna Domańska; Ewa Sajnaga; Elzbieta Mazur; Rafał Zieliński; Ryszard Szyszka
Journal:  Mol Cell Biochem       Date:  2006-08-24       Impact factor: 3.396

6.  Phosphorylation regulates the stability of the regulatory CK2beta subunit.

Authors:  Cunjie Zhang; Greg Vilk; David A Canton; David W Litchfield
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

7.  Comparative analysis of Saccharomyces cerevisiae WW domains and their interacting proteins.

Authors:  Jay R Hesselberth; John P Miller; Anna Golob; Jason E Stajich; Gregory A Michaud; Stanley Fields
Journal:  Genome Biol       Date:  2006-04-10       Impact factor: 13.583

8.  Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.

Authors:  X Xu; P A Toselli; L D Russell; D C Seldin
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

9.  Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

Authors:  Jing Jin; F Donelson Smith; Chris Stark; Clark D Wells; James P Fawcett; Sarang Kulkarni; Pavel Metalnikov; Paul O'Donnell; Paul Taylor; Lorne Taylor; Alexandre Zougman; James R Woodgett; Lorene K Langeberg; John D Scott; Tony Pawson
Journal:  Curr Biol       Date:  2004-08-24       Impact factor: 10.834

10.  An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.

Authors:  James S Duncan; Laszlo Gyenis; John Lenehan; Maria Bretner; Lee M Graves; Timothy A Haystead; David W Litchfield
Journal:  Mol Cell Proteomics       Date:  2008-02-07       Impact factor: 5.911

View more
  10 in total

1.  Protein kinase CK2 and new binding partners during spermatogenesis.

Authors:  Nadja Mannowetz; Sabine Kartarius; Gunther Wennemuth; Mathias Montenarh
Journal:  Cell Mol Life Sci       Date:  2010-06-04       Impact factor: 9.261

2.  Threonine 393 of beta-catenin regulates interaction with Axin.

Authors:  Hao Wu; Karen Symes; David C Seldin; Isabel Dominguez
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

3.  Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.

Authors:  Jiping Yue; Ruchi Shukla; Rosita Accardi; Isabelle Zanella-Cleon; Maha Siouda; Marie-Pierre Cros; Vladimir Krutovskikh; Ishraq Hussain; Yamei Niu; Shiqiong Hu; Michel Becchi; Pierre Jurdic; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

4.  A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway.

Authors:  Ying Zheng; Hongwei Qin; Stuart J Frank; Luqin Deng; David W Litchfield; Ayalew Tefferi; Animesh Pardanani; Fang-Tsyr Lin; Jingzhi Li; Bingdong Sha; Etty N Benveniste
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

5.  Mutant spastin proteins promote deficits in axonal transport through an isoform-specific mechanism involving casein kinase 2 activation.

Authors:  Lanfranco Leo; Carina Weissmann; Matthew Burns; Minsu Kang; Yuyu Song; Liang Qiang; Scott T Brady; Peter W Baas; Gerardo Morfini
Journal:  Hum Mol Genet       Date:  2017-06-15       Impact factor: 6.150

6.  The functioning of the Drosophila CPEB protein Orb is regulated by phosphorylation and requires casein kinase 2 activity.

Authors:  Li Chin Wong; Alexandre Costa; Ian McLeod; Ali Sarkeshik; John Yates; Saw Kyin; David Perlman; Paul Schedl
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

7.  Involvement of Plasmodium falciparum protein kinase CK2 in the chromatin assembly pathway.

Authors:  Eeshita G Dastidar; Guillem Dayer; Zoe M Holland; Dominique Dorin-Semblat; Aurélie Claes; Arnaud Chêne; Amit Sharma; Romain Hamelin; Marc Moniatte; Jose-Juan Lopez-Rubio; Artur Scherf; Christian Doerig
Journal:  BMC Biol       Date:  2012-01-31       Impact factor: 7.431

8.  Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.

Authors:  Laszlo Gyenis; James S Duncan; Jacob P Turowec; Maria Bretner; David W Litchfield
Journal:  J Proteome Res       Date:  2011-10-13       Impact factor: 4.466

9.  Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.

Authors:  Laura Quotti Tubi; Carmela Gurrieri; Alessandra Brancalion; Laura Bonaldi; Roberta Bertorelle; Sabrina Manni; Laura Pavan; Federica Lessi; Renato Zambello; Livio Trentin; Fausto Adami; Maria Ruzzene; Lorenzo A Pinna; Gianpietro Semenzato; Francesco Piazza
Journal:  J Hematol Oncol       Date:  2013-10-12       Impact factor: 17.388

10.  Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.

Authors:  Katsutoshi Sato; Amol A Padgaonkar; Stacey J Baker; Stephen C Cosenza; Olga Rechkoblit; D R C Venkata Subbaiah; Josep Domingo-Domenech; Alison Bartkowski; Elisa R Port; Aneel K Aggarwal; M V Ramana Reddy; Hanna Y Irie; E Premkumar Reddy
Journal:  Nat Commun       Date:  2021-08-03       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.